ACADIA Pharmaceuticals Inc.

ACAD · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$319,589$188,657$114,846$147,435
Short-Term Investments$436,404$250,208$301,977$373,271
Receivables$104,695$102,350$63,080$65,344
Inventory$21,949$35,819$6,636$7,881
Other Curr. Assets$55,681$39,091$21,398$23,892
Total Curr. Assets$938,318$616,125$507,937$617,823
Property Plant & Equip (Net)$50,786$56,467$61,594$66,315
Goodwill$0$0$0$0
Intangibles$119,782$65,490$0$0
Long-Term Investments$0$5,770$12,970$0
Tax Assets$0$0$0$0
Other NC Assets$78,870$5,104$5,311$15,984
Total NC Assets$249,438$132,831$79,875$82,299
Other Assets$0$0$0$0
Total Assets$1,187,756$748,956$587,812$700,122
Liabilities
Payables$16,192$17,543$12,746$6,876
Short-Term Debt$9,958$9,405$9,305$8,304
Tax Payable$12,016$1,564$377$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$356,704$225,742$103,202$80,888
Total Curr. Liab.$394,870$254,254$125,630$96,068
LT Debt$42,037$47,800$52,695$56,126
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$18,056$15,147$9,074$7,034
Total NC Liab.$60,093$62,947$61,769$63,160
Other Liabilities$0$0$0$0
Cap. Leases$51,995$47,800$62,000$64,430
Total Liabilities$454,963$317,201$187,399$159,228
Equity
Pref Stock$0$0$0$0
Common Stock$16$16$16$16
Retained Earnings-$2,204,386-$2,430,837-$2,369,551-$2,153,576
AOCI$292$24-$975-$192
Other Equity$2,936,871$2,862,552$2,770,923$2,694,646
Total Equity$732,793$431,755$400,413$540,894
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,187,756$748,956$587,812$700,122
Net Debt-$267,594-$131,452-$52,846-$83,005